The trademark application CELLCOMPASS was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on July 18, 2022, and it was registered by office on October 25, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 42 with Providing temporary use of on-line non-downloadable software for placing, verifying, tracking, monitoring and fulfilling orders for therapeutic treatments in the field of personalized cell therapy..
The mark was filed in class 44 with following description of goods:
Providing information in the field of personalized cell therapy
Providing medical information on immunotherapy
Providing information on custom ordering and manufacture of pharmaceutical products for therapeutic use in immunotherapy..